Merit Medical Systems, Inc. provided earnings guidance for the Fiscal Year 2022. For the period, the company expects Net revenue in the range of $1.117 billion to $1.140 billion, representing an increase of approximately 4% to 6% year-over-year, as compared to net revenue of $1.075 billion for the twelve months ended December 31, 2021. GAAP net income in the range of $75.4 million to $84.0 million, or $1.30 to $1.45 per diluted share, compared to GAAP net income of $48.5 million, or $0.84 per diluted share, for the twelve months ended December 31, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.88 USD | +0.53% | -0.02% | +6.48% |
05-21 | Merit Medical Launches basixSKY Inflation Device | CI |
05-16 | Merit Medical Elects Silvia M. Perez as New Director | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.48% | 4.7B | |
-7.57% | 177B | |
-2.16% | 106B | |
-6.99% | 65.54B | |
-4.65% | 47.09B | |
+7.38% | 43.43B | |
+8.14% | 41.77B | |
+14.07% | 29.55B | |
+15.53% | 24.83B | |
-5.97% | 23.54B |
- Stock Market
- Equities
- MMSI Stock
- News Merit Medical Systems, Inc.
- Merit Medical Systems, Inc. Provides Earnings Guidance for the Fiscal Year 2022